Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments.
Kolinjivadi AM
,
Sannino V
,
De Antoni A
,
Zadorozhny K
,
Kilkenny M
,
Técher H
,
Baldi G
,
Shen R
,
Ciccia A
,
Pellegrini L
,
Krejci L
,
Costanzo V
.
???displayArticle.abstract??? Brca2 deficiency causes Mre11-dependent degradation of nascent DNA at stalled forks, leading to cell lethality. To understand the molecular mechanisms underlying this process, we isolated Xenopus laevis Brca2. We demonstrated that Brca2 protein prevents single-stranded DNA gap accumulation at replication fork junctions and behind them by promoting Rad51 binding to replicating DNA. Without Brca2, forks with persistent gaps are converted by Smarcal1 into reversed forks, triggering extensive Mre11-dependent nascent DNA degradation. Stable Rad51 nucleofilaments, but not RPA or Rad51T131P mutant proteins, directly prevent Mre11-dependent DNA degradation. Mre11 inhibition instead promotes reversed fork accumulation in the absence of Brca2. Rad51 directly interacts with the Pol α N-terminal domain, promoting Pol α and δ binding to stalled replication forks. This interaction likely promotes replication fork restart and gap avoidance. These results indicate that Brca2 and Rad51 prevent formation of abnormal DNA replication intermediates, whose processing by Smarcal1 and Mre11 predisposes to genome instability.
Figure 1. Brca2 and Rad51 Function in DNA Replication(A) The Xenopus Brca2 protein. See also Figures S1 and S2.(B) Brca2 and Rad51 immunoprecipitations (IPs) and western blots (WBs).(C) Brca2 and Rad51 depletion from egg extract.(D) Chromatin binding time course with or without recombinant geminin. NS, no sperm nuclei.(E) Brca2 and Rad51 chromatin binding normalized to histone H2B. Mean optical density ± SD of three experiments (n = 3) is shown.(F) Chromatin binding time course in mock and Brca2-depleted extracts.(G) Relative incorporation of α-32P-dCTP over time in mock and Brca2-depleted extracts. Counts per minute for mock-treated extracts at 150 min were considered as 100%.(H) DNA replication in extracts depleted as indicated and reconstituted with 50 ng/μL recombinant Brca2c or Brca2d proteins. L-APH (3 μM) or L-APH plus S1 nuclease (0.1 U/μL) was added at the start where indicated. Nuclei were pre-treated with MMS (1% v/v) or UV (1,000 J/m2) where indicated. Counts per minute in mock-treated extracts at 150 min were considered as 100%. Mean values ± SD (n = 3) are shown.See also Figures S1âS3.
Figure 2. ssDNA Gaps and Nascent DNA Degradation in the Absence of Brca2(A) EM micrographs showing RIs isolated from mock-treated (left) and Brca2- (center) and Rad51-depleted extracts (right). Empty arrows indicate newly replicated strands. Arrowheads indicate ssDNA gaps at fork junctions.(B) Graph showing the distribution of fork gaps with different lengths. Bars indicate the percentage of RIs with different gap lengths in mock-treated and Brca2- or Rad51-depleted extracts. Mean values ± SEM relative to 150 RIs counted in three experiments (n = 3) are shown.(C) EM micrograph showing RIs isolated from Brca2-depleted extract. The full black arrow indicates an internal ssDNA fork gap.(D) Distribution of RIs with the indicated number of internal gaps in mock-treated and Brca2- or Rad51-depleted extracts. Mean values ± SEM (n = 3) are shown.(E) EM micrograph showing an RI isolated from an undepleted extract incubated with H-APH (1.5 mM) as shown.(F) EM micrograph showing RIs isolated from mock-treated (top) or Brca2-depleted (bottom) extracts treated with H-APH as in (E). Insets show a higher magnification of replication bubbles. Empty arrows indicate double-stranded DNA. Arrowheads show ssDNA.See also Figure S4.
Figure 3. Brca2- and Rad51-Mediated Protection from Mre11(A) Top: experimental scheme. Bottom: relative percentage of residual biotin-dUTP in sperm nuclei quantified using a fluorescence method. The fluorescence intensity of mock at 0 min was considered as 100%. Extracts were treated as indicated and supplemented with 100 μM mirin or recombinant Brca2c or Brca2d. Mean values ± SD (n = 3) are shown.(B and C) Gel showing the effect of Rad51WT and Rad51T131P (B) or RPA complex (C) pre-incubation with 5â² fluorescently labeled DNA substrate (20 nM), shown in the scheme containing phosphorothioate bonds (s), and subsequent incubation with Mre11 (30 nM). Reactions were resolved on denaturing 30% polyacrylamide gel.(D) Mre11-dependent DNA degradation rates in the presence of Rad51WT, Rad51T131P, or RPA relative to the amount of substrate shown in (B), lane (â), which was considered as 100%. Mean values ± SD (n = 3) are shown.(E) Electrophoretic mobility shift assay showing binding of Rad51WT, Rad51T131P, or RPA to the same fluorescently labeled DNA substrate (20 nM) resolved on 0.8% agarose gel.See also Figures S4 and S5.
Figure 4. Smarcal1-Dependent Regulation of RVFs(A) EM micrograph showing RVF intermediate isolated from extracts treated with H-APH (1.5 mM). The arrow indicates a double-stranded reversed branch. The arrowhead indicates the single-stranded tail of the reversed branch. The inset shows a high magnification of the RVF junction.(B) Chromatin binding of the indicated factors at the indicated times following buffer or H-APH supplementation. Buffer and H-APH were added to egg extract 45 min after sperm nuclei. NS, absence of sperm nuclei.(C) RVF frequency in extracts treated as indicated. Mean values ± SEM (n = 3) are shown. â,ââ,âââp < 0.01, obtained by unpaired t test between the marked couples.(D) Scheme showing the assay to quantify RVFs with ssDNA tails (STAR Methods).(E) ELISA detection of BrdU in nascent ssDNA in nuclei incubated in extracts treated as shown. Where indicated, extracts were supplemented with 5 ng/μL recombinant human Smarcal1WT or catalytically dead Smarcal1HD. Mean intensity values ± SD (n = 3) are shown.See also Figure S6.
Figure 5. RVFs and Nascent DNA Degradation(A) Residual biotin-dUTP in nuclei replicated in extracts treated as shown. Where indicated, extracts were Smarcal1-depleted and supplemented with buffer or 5 ng/μL recombinant Smarcal1WT or Smarcal1HD proteins. The fluorescence intensity of mock at 0 min was considered as 100%.(B) ELISA detection of BrdU in nascent ssDNA in nuclei incubated in extracts treated as shown. Mean intensity values ± SD (n = 3) are shown.(C and D) Gel showing the effect of Rad51WT and Rad51T131P (C) or RPA (D) pre-incubation with 5â² fluorescently labeled RVF, shown in the scheme, and subsequent incubation with Mre11. Reactions were resolved on denaturing 30% polyacrylamide gel.(E) Mre11-dependent DNA degradation rates in the presence of Rad51WT, Rad51T131P, or RPA relative to the amount of substrate (20 nM) shown in (C), lane (â), which was considered as 100%. Mean values ± SD (n = 3) are shown.(F) DNA binding of Rad51 WT or RPA to the same fluorescently labeled RVF DNA substrate (20 nM) resolved on 0.8% agarose gel.See also Figure S6.
Figure 6. Rad51-Pol α Interaction at Stalled Forks(A) WB of egg extract IPs using the indicated antibodies. Flowthrough (FT) and extract input (XE) are also shown.(B) Top: Coomassie-stained gel showing pull-down experiments using Rad51 and hPol α complexes made of the Pol α catalytic subunit, B subunit, Pri-S, and Pri-L. The Pol α catalytic and B subunits were either full-length or missing the first 333 and 148 amino acids, respectively (ÎNTD). His-tagged Pri-S was used for the pull-down. Bottom: WB with anti-Rad51 antibodies of samples shown at the top.(C) Top: Coomassie-stained gel showing pull-down experiments using Rad51 and the first 109 amino acids of Pol α (MBP-Pol α NTD) bound to amylose resin. Bottom: WB with anti-Rad51 antibodies of the samples shown at the top.(D) Coomassie-stained gel showing pull-down experiments using Rad51 and the first 109 amino acids of Pol α (MBP-Pol α NTD) bound to amylose resin in the presence of increasing amounts of BRC4 peptide.(E) Chromatin binding time course following addition of recombinant human full-length (hPol α) and NTD truncated (ÎNTD) complexes shown in (B) in the presence of DMSO or M-APH. Anti-Xenopus Pol α p180 and anti-human Pol α p180 were used for the WB shown at the top and center, respectively.(F) IPOND showing proteins bound to chromatin containing nascent DNA following biotin pull- down with streptavidin beads. Extracts were supplemented with M-APH 45 min after nuclei addition and pulse-labeled for 10 min with biotin-dUTP as indicated. Pol α, δ, and ε inputs are also shown.(G) DNA replication in mock-treated or Rad51-depleted restarting extracts (Figure S7F). Values in mock-treated stalling extracts transferred to mock-treated restarting extracts were considered as 100%. Mean values ± SD (n = 3) are shown. See also Figure S7.
Figure 7. General ModelSee Discussion for an explanation.
Anand,
Phosphorylated CtIP Functions as a Co-factor of the MRE11-RAD50-NBS1 Endonuclease in DNA End Resection.
2016, Pubmed
Anand,
Phosphorylated CtIP Functions as a Co-factor of the MRE11-RAD50-NBS1 Endonuclease in DNA End Resection.
2016,
Pubmed
Aze,
Centromeric DNA replication reconstitution reveals DNA loops and ATR checkpoint suppression.
2016,
Pubmed
,
Xenbase
Berti,
Replication stress: getting back on track.
2016,
Pubmed
Bétous,
Substrate-selective repair and restart of replication forks by DNA translocases.
2013,
Pubmed
Bétous,
SMARCAL1 catalyzes fork regression and Holliday junction migration to maintain genome stability during DNA replication.
2012,
Pubmed
Byun,
Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint.
2005,
Pubmed
,
Xenbase
Cejka,
DNA End Resection: Nucleases Team Up with the Right Partners to Initiate Homologous Recombination.
2015,
Pubmed
Chavdarova,
Srs2 promotes Mus81-Mms4-mediated resolution of recombination intermediates.
2015,
Pubmed
Ciccia,
Stressing Out About RAD52.
2016,
Pubmed
Ciccia,
Polyubiquitinated PCNA recruits the ZRANB3 translocase to maintain genomic integrity after replication stress.
2012,
Pubmed
Ciccia,
The SIOD disorder protein SMARCAL1 is an RPA-interacting protein involved in replication fork restart.
2009,
Pubmed
Costanzo,
Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage.
2000,
Pubmed
,
Xenbase
Couch,
ATR phosphorylates SMARCAL1 to prevent replication fork collapse.
2013,
Pubmed
,
Xenbase
Courcelle,
RecA-dependent recovery of arrested DNA replication forks.
2003,
Pubmed
Davies,
Interaction with the BRCA2 C terminus protects RAD51-DNA filaments from disassembly by BRC repeats.
2007,
Pubmed
Ding,
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies.
2016,
Pubmed
Errico,
Mta2 promotes Tipin-dependent maintenance of replication fork integrity.
2014,
Pubmed
,
Xenbase
Errico,
Tipin is required for stalled replication forks to resume DNA replication after removal of aphidicolin in Xenopus egg extracts.
2007,
Pubmed
,
Xenbase
Esashi,
Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2.
2007,
Pubmed
Flynn,
ATR: a master conductor of cellular responses to DNA replication stress.
2011,
Pubmed
Fumasoni,
Error-free DNA damage tolerance and sister chromatid proximity during DNA replication rely on the Polα/Primase/Ctf4 Complex.
2015,
Pubmed
Hashimoto,
RAD51- and MRE11-dependent reassembly of uncoupled CMG helicase complex at collapsed replication forks.
2011,
Pubmed
,
Xenbase
Hashimoto,
Studying DNA replication fork stability in Xenopus egg extract.
2011,
Pubmed
,
Xenbase
Hashimoto,
Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis.
2010,
Pubmed
,
Xenbase
Higgs,
BOD1L Is Required to Suppress Deleterious Resection of Stressed Replication Forks.
2015,
Pubmed
Holloman,
Unraveling the mechanism of BRCA2 in homologous recombination.
2011,
Pubmed
Jasin,
Homologous repair of DNA damage and tumorigenesis: the BRCA connection.
2002,
Pubmed
Jensen,
Purified human BRCA2 stimulates RAD51-mediated recombination.
2010,
Pubmed
Jeyasekharan,
DNA damage regulates the mobility of Brca2 within the nucleoplasm of living cells.
2010,
Pubmed
Kim,
Interactions of human replication protein A with oligonucleotides.
1994,
Pubmed
Kowalczykowski,
An Overview of the Molecular Mechanisms of Recombinational DNA Repair.
2015,
Pubmed
Lopes,
Electron microscopy methods for studying in vivo DNA replication intermediates.
2009,
Pubmed
Lopes,
The DNA replication checkpoint response stabilizes stalled replication forks.
2001,
Pubmed
Marini,
Unwinding of synthetic replication and recombination substrates by Srs2.
2012,
Pubmed
McVey,
Eukaryotic DNA Polymerases in Homologous Recombination.
2016,
Pubmed
Nam,
ATR signalling: more than meeting at the fork.
2011,
Pubmed
Nik-Zainal,
Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
2016,
Pubmed
Pellegrini,
The Pol α-primase complex.
2012,
Pubmed
Pellegrini,
New Insights into the Mechanism of DNA Duplication by the Eukaryotic Replisome.
2016,
Pubmed
Petermann,
Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair.
2010,
Pubmed
Qiu,
Srs2 prevents Rad51 filament formation by repetitive motion on DNA.
2013,
Pubmed
Räschle,
Mechanism of replication-coupled DNA interstrand crosslink repair.
2008,
Pubmed
,
Xenbase
Ray Chaudhuri,
Replication fork stability confers chemoresistance in BRCA-deficient cells.
2016,
Pubmed
Reuter,
BRCA2 diffuses as oligomeric clusters with RAD51 and changes mobility after DNA damage in live cells.
2014,
Pubmed
Sannino,
Studying essential DNA metabolism proteins in Xenopus egg extract.
2016,
Pubmed
,
Xenbase
Schlacher,
A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2.
2012,
Pubmed
Schlacher,
Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.
2011,
Pubmed
Sigurdsson,
Basis for avid homologous DNA strand exchange by human Rad51 and RPA.
2001,
Pubmed
Simon,
Structure of human Cdc45 and implications for CMG helicase function.
2016,
Pubmed
,
Xenbase
Sirbu,
Identification of proteins at active, stalled, and collapsed replication forks using isolation of proteins on nascent DNA (iPOND) coupled with mass spectrometry.
2013,
Pubmed
Spies,
Nek1 Regulates Rad54 to Orchestrate Homologous Recombination and Replication Fork Stability.
2016,
Pubmed
Thompson,
Homologous recombinational repair of DNA ensures mammalian chromosome stability.
2001,
Pubmed
Thorslund,
BRCA2: a universal recombinase regulator.
2007,
Pubmed
Toledo,
Targeting ATR and Chk1 kinases for cancer treatment: a new model for new (and old) drugs.
2011,
Pubmed
Trenz,
ATM and ATR promote Mre11 dependent restart of collapsed replication forks and prevent accumulation of DNA breaks.
2006,
Pubmed
,
Xenbase
Van,
Continued primer synthesis at stalled replication forks contributes to checkpoint activation.
2010,
Pubmed
,
Xenbase
Wang,
A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination.
2015,
Pubmed
Yang,
BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure.
2002,
Pubmed
Zellweger,
Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells.
2015,
Pubmed